| 000 | 01203 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515230747.0 | ||
| 264 | 0 | _c20110726 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/eye.2010.96 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaniwaki, L | |
| 245 | 0 | 0 |
_aEffect of lyophilization on the in vitro biological activity of bevacizumab. _h[electronic resource] |
| 260 |
_bEye (London, England) _cOct 2010 |
||
| 300 |
_a1628-9 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aFreeze Drying |
| 650 | 0 | 4 |
_aPreservation, Biological _xmethods |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _ximmunology |
| 700 | 1 | _aMendonça, R | |
| 700 | 1 | _aCunha-Júnior, A S | |
| 700 | 1 | _aFaraco, A A G | |
| 700 | 1 | _aRibeiro, J A S | |
| 700 | 1 | _aScott, I U | |
| 700 | 1 | _aJorge, R | |
| 773 | 0 |
_tEye (London, England) _gvol. 24 _gno. 10 _gp. 1628-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/eye.2010.96 _zAvailable from publisher's website |
| 999 |
_c19925232 _d19925232 |
||